This is with reference to our prior intimation dated April 15, 2026, regarding the meeting of the Board of Directors of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) scheduled to be held today, i.e., Monday, April 20, 2026, inter alia, to consider and approve the preferential issue of equity shares of the Company on a private placement basis, along with other business matters.We wish to inform you that the said Board Meeting has been deferred due to the requirement of additional time for completion of certain procedural and documentation-related formalities in connection with the proposed preferential issue.